His work focuses on how microbial ecosystems interact with human physiology, including: Gut barrier function and intestinal permeability Mucus-associated microbiota (Akkermansia-related systems) Oralgut microbiome axis Short-chain fatty acids (SCFAs) and metabolic signaling Circadian rhythmmicrobiome interactions Clinical Research Contributions He has contributed to multiple clinical-stage microbiome programs, supporting bacterial strain discovery, optimization, and formulation design across different therapeutic areas, including: Active Ulcerative Colitis (Inflammatory Bowel Disease) Hyperoxaluria (Oxalate Metabolism Disorder) Microbiome-driven gut health and inflammatory conditions These studies were part of broader clinical development programs evaluating microbiome-based approaches
So, based on this new study, I dropped my supplement recommendations down to that 50 a day or 2000 a week
Yang Y, Liu L, Zhang X, Jiang X, Wang L
The re-synthesis process is often impaired during diseases status
doi:10.1016/j.euf.2018.04.013
The timescale of such solvent relaxation depends on the environment, being very fast in non-viscous solvent (happening well within the excited-state lifetime of the fluorophore) but being much slower in motionally restricted environments, such as viscous solvents or the compact, tightly packed interior of a folded protein